The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 23.53%.However, over the last six months, we can see a weaker performance of 51.20%. Over the last 30 days, the price of LXRX has leaped by -6.44%. And in the last five days, it has surged by 11.18%.
Lexicon Pharmaceuticals Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $3.73 on 02/16/24 and the lowest value was $0.92 on 11/10/23.
52-week price history of LXRX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Lexicon Pharmaceuticals Inc’s current trading price is -49.33% away from its 52-week high, while its distance from the 52-week low is 105.43%. The stock’s price range during this period has varied between$0.92 and $3.73. The Lexicon Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.63 million for the day, a figure considerably lower than their average daily volume of 4.52 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Lexicon Pharmaceuticals Inc (LXRX) has experienced a quarterly decline of -17.83% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 465.39M and boasts a workforce of 285 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.9730, with a change in price of +0.5900. Similarly, Lexicon Pharmaceuticals Inc recorded 4,060,541 in trading volume during the last 100 days, posting a change of +45.38%.
LXRX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for LXRX stands at 0.37. Similarly, the long-term debt-to-equity ratio is also 0.36.
LXRX Stock Stochastic Average
Lexicon Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 30.39%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 73.31%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 56.13% and 50.06%, respectively.
